To clarify the exact RBP in nuclear EGFR-mediated cancer progression, we evaluated the clinical value of those RBPs in TNBC and found NONO was significantly upregulated in TNBC and closely associated with breast cancer malignancy. The gene discussed is EGFR; the disease is breast carcinoma.